The Aporia
Wang, O. (2026, September 17). Donald Trump presses Xi Jinping on fentanyl precursors ahead of Washington summit. South China Morning Post. https://www.scmp.com/news/china/diplomacy/article/3367840/donald-trump-presses-xi-jinping-fentanyl-precursors-ahead-washington-summit?utm_source=rss_feed
Wang, Orange. “Donald Trump presses Xi Jinping on fentanyl precursors ahead of Washington summit.” South China Morning Post, 17 Sept. 2026, https://www.scmp.com/news/china/diplomacy/article/3367840/donald-trump-presses-xi-jinping-fentanyl-precursors-ahead-washington-summit?utm_source=rss_feed.
Wang, Orange. “Donald Trump presses Xi Jinping on fentanyl precursors ahead of Washington summit.” South China Morning Post, September 17, 2026. https://www.scmp.com/news/china/diplomacy/article/3367840/donald-trump-presses-xi-jinping-fentanyl-precursors-ahead-washington-summit?utm_source=rss_feed.
Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.
On Wednesday, Donald Trump pressed Xi Jinping on fentanyl precursors ahead of a Washington summit, according to the White House's annual determination report submitted to US Congress. The report identifies China as the world’s largest producer of precursor chemicals for illicit drugs like fentanyl and methamphetamine affecting the United States. Despite this designation, Trump claims he personally requested China last year to implement new export licensing requirements for these chemicals before sending them to North America. This comes a week after US security agencies celebrated progress in counternarcotics law enforcement cooperation with Chinese counterparts, highlighting a mixed narrative of collaboration and criticism between the two nations.